17 Percent of investors who agree ESG PERFORMANCE KEY INDICATOR OF PREMIUM VALUATION, BETTER RETURNS, AND RESILIENCE 2021 Special Report: Healthcare Institutional Investors: Q23. Please indicate the extent to which you agree or disagree with the following statements. Shown NET agree T3B. Base: 3 - market average n=225 A healthcare company with strong ESG performance deserves a premium valuation to its share price 81 % Healthcare companies that prioritize ESG represent better opportunities for long - term returns than healthcare companies that do not 79 % A healthcare company with strong ESG performance is more resilient in a crisis 76 % 3 - mkt average 3 - mkt average 3 - mkt average